Kinnate Biopharma Inc. Analysis
| Analyst Ratings |
|
Average Target Price
|
30.14
|
|
Average Rating
|
4.38
|
|
# Strong Buys
|
4
|
|
# Buys
|
3
|
|
# Holds
|
1
|
|
# Sells
|
0
|
|
# Strong Sells
|
0
|
| Quarterly Earnings History |
| Quarter |
EPS Estimate |
EPS Actual |
EPS Difference |
Surprise Percent |
|
2022-09-30
|
-0.61
|
-0.70
|
-0.09
|
-14.75%
|
|
2022-06-30
|
-0.64
|
-0.62
|
0.02
|
3.13%
|
|
2022-03-31
|
-0.61
|
-0.61
|
0.00
|
0.00%
|
|
2021-12-31
|
-0.59
|
-0.60
|
-0.01
|
-1.69%
|
|
2021-09-30
|
-0.54
|
-0.57
|
-0.03
|
-5.56%
|
|
2021-06-30
|
-0.43
|
-0.49
|
-0.06
|
-13.95%
|
|
2021-03-31
|
-0.36
|
-0.40
|
-0.04
|
-11.11%
|
|
2020-12-31
|
-0.37
|
-0.32
|
0.05
|
13.51%
|
| Annual Earnings History |
| Fiscal Year End |
EPS |
|
2022-12-31
|
-1.93
|
|
2021-12-31
|
-2.06
|
|
2020-12-31
|
-1.30
|